SCHEMBL7013247

SCHEMBL7013247

O=C(O)COc1cccn2cccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GLA P06280 1/20 0.51
ALDH1A1 P00352 3/20 0.49
PTGDR2 Q9Y5Y4 3/20 0.49
KDM4E B2RXH2 2/20 0.49
HPGD P15428 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
ALOX15 P16050 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TBXAS1 P24557 2/20 0.44
PKM P14618 2/20 0.44
MAPT P10636 1/20 0.44
CASP1 P29466 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PLA2G2A P14555 3/20 0.41
PLA2G10 O15496 1/20 0.41
PLA2G6 O60733 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29682135 0.76 L3MBTL1 (0.80) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
SCHEMBL340762 0.76 L3MBTL1 (0.80) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
Ammonia Solution, Strong SCHEMBL28240461 0.74 L3MBTL1 (0.77) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
SCHEMBL17972755 0.74 L3MBTL1 (0.50) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
SCHEMBL8322723 0.72 PLA2G1B (0.49) POLBSMN1; SMN2PLA2G2APLA2G10PLA2G1B
SCHEMBL10202539 0.72 MEN1 (0.55) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
SCHEMBL1145948 0.71 KMT2A (0.62) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
SCHEMBL8115884 0.71 L3MBTL1 (0.71) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
Succinic Acid SCHEMBL6888240 0.71 L3MBTL1 (0.71) L3MBTL1POLBSMN1; SMN2GLAALDH1A1
SCHEMBL17311050 0.70 L3MBTL1 (0.54) L3MBTL1POLBSMN1; SMN2GLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645976-B1 Nonpancreatic secretory phospholipase (sPLA2) supressors such as 2-(3-Benzyl-8-hydroxy-2-ethylindolizin-1-yl)acetamide, administered to control release of fatty acid and prevent the arachidonic acid cascade; septic shock ELI LILLY AND COMPANY 2003-11-11 US disclosed
EP-0772596-B1 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 2003-10-01 EP disclosed
EP-0772596-A4 INDOLIZINE sPLA2 INHIBITORS LILLY CO ELI (US) 1999-01-13 EP disclosed
EP-0772596-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1997-05-14 EP disclosed
WO-1996003383-A1 INDOLIZINE sPLA2 INHIBITORS ELI LILLY AND COMPANY (US) 1996-02-08 WO disclosed